Rasburicase in Treating or Preventing High Levels of Uric Acid in the Blood and Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumors - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00086918

Locations


United States, California
	Children's Hospital and Health Center - San Diego
	San Diego, California, United States, 92123-4282

United States, Colorado
	Rocky Mountain Cancer Centers - Denver Midtown
	Denver, Colorado, United States, 80218

United States, Florida
	University of Florida Health Science Center - Jacksonville
	Jacksonville, Florida, United States, 32209

United States, Louisiana
	Ochsner Cancer Institute at Ochsner Clinic Foundation
	New Orleans, Louisiana, United States, 70121

United States, Massachusetts
	Massachusetts General Hospital Cancer Center
	Boston, Massachusetts, United States, 02114-2617

United States, New York
	New York Medical College
	Valhalla, New York, United States, 10595
	Roswell Park Cancer Institute
	Buffalo, New York, United States, 14263-0001

United States, North Carolina
	Duke Comprehensive Cancer Center
	Durham, North Carolina, United States, 27705

United States, Oklahoma
	Children's Hospital at Oklahoma University Medical Center
	Oklahoma City, Oklahoma, United States, 73104

United States, Pennsylvania
	Abramson Cancer Center of the University of Pennsylvania
	Philadelphia, Pennsylvania, United States, 19104-4283

United States, Tennessee
	St. Jude Children's Research Hospital
	Memphis, Tennessee, United States, 38105

United States, Texas
	M.D. Anderson Cancer Center at University of Texas
	Houston, Texas, United States, 77030-4009

United States, West Virginia
	Mary Babb Randolph Cancer Center at West Virginia University Hospitals
	Morgantown, West Virginia, United States, 26506-9162

Sponsors and Collaborators

Prologue Research International

Investigators


Study Chair:	Richard A. Gams, MD	Prologue Research International